Fairchem Organics Submits Q3FY26 Earnings Call Audio Recording Under SEBI Compliance
Fairchem Organics Limited has submitted the audio recording of its earnings conference call held on February 9, 2026, discussing Q3FY26 results under SEBI regulatory compliance. The company reported challenging performance with Q3FY26 revenue declining 12% to ₹1,001 million and nine-month revenue dropping 17.8% to ₹3,427 million, attributed to weaker paints segment demand and export challenges.

*this image is generated using AI for illustrative purposes only.
Fairchem Organics Limited has submitted the audio recording of its earnings conference call held on February 9, 2026, discussing Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The submission was made under Regulation 30 read with Schedule III, Part A of SEBI (LODR) Regulations, 2015.
Q3FY26 Financial Performance
The earnings presentation reveals the company's financial metrics for the third quarter:
| Metric: | Q3FY26 | Performance |
|---|---|---|
| Revenue from Operations: | ₹1,001 million | 12.0% decline Y-o-Y |
| EBITDA: | ₹42 million | 4.20% margin |
| Profit Before Tax: | ₹7 million | Significant decline |
| PAT (w/o exceptional item): | ₹6 million | 0.60% margin |
Nine Months Performance Analysis
For the nine-month period ending December 31, 2025, the company reported:
| Parameter: | 9M FY26 | Performance |
|---|---|---|
| Revenue from Operations: | ₹3,427 million | 17.8% decline Y-o-Y |
| EBITDA: | ₹136 million | 3.97% margin |
| PAT: | ₹35 million | Including exceptional items |
| PAT (w/o exceptional item): | ₹25 million | 0.73% margin |
Earnings Call Documentation and Compliance
The audio recording of the earnings call held on Monday, February 9, 2026, from 3:00 PM onwards is now available on the company's website. Company Secretary Jatin Jain formally communicated the submission to both NSE and BSE, ensuring full regulatory compliance.
| Compliance Details: | Information |
|---|---|
| Call Date: | February 9, 2026 |
| Call Time: | 3:00 PM onwards |
| Website Link: | Available on investor relations section |
| Regulation: | SEBI (LODR) Regulations, 2015 |
Business Challenges and Market Dynamics
The presentation highlights several factors impacting performance. Revenue decline was attributed to weaker offtake from the paints segment and discontinuation of prime product exports to the USA. The paints sector's reduced material lifting is linked to market share challenges from new player entry, affecting both volume and realizations.
Raw material prices remained elevated due to higher custom duty (currently 16.5% versus original 5.5%) as global vegetable oil markets continued trading firm. Dimer Acid margins stayed under pressure, intensified by aggressive Chinese pricing and unchanged 7.5% import duty.
Export Strategy and Future Outlook
With recent announcements of level playing tariff with the US and proposed FTA with EU/UK, the company expressed confidence in quickly ramping up sales of high-margin products in export markets. The presentation notes that Fairchem is the only Isostearic Acid manufacturer in India and already exports this product to several countries.
Company Overview and Competitive Position
The company emphasizes its 29-year legacy as a leading manufacturer of Oleo Chemicals and Nutraceuticals. Fairchem operates a state-of-the-art manufacturing facility established in 1995, producing key products including Dimer Acid, Linoleic Acid, Palmitic Acid, Monomer Acid, Isostearic Acid, Mixed Tocopherols, and Sterol concentrate.
Historical Stock Returns for Fairchem Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.56% | -8.20% | -11.62% | -32.04% | -43.71% | -16.05% |


































